4th Quarter - Report

PODESTA GROUP, INC. for AMPHASTAR PHARMACEUTICALS, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA Reform Abbreviated New Drug Application (ANDA) process and Follow-on-Biologics

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN New —
RANDALL GERARD Senate Commerce, Science & Transportation
ANDREW J LEWIN New Leg. Asst & Director, Rep. Max Sandlin
ANTHONY PODESTA New —
NICOLE C YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.